MedPath

X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Public
Established
2014-01-01
Employees
93
Market Cap
$117.9M
Website
http://www.x4pharma.com

A Study Comparing Once-Daily vs. Twice-Daily Dosing of X4P-001 in Healthy Volunteers

Phase 1
Terminated
Conditions
Healthy
Interventions
First Posted Date
2016-02-12
Last Posted Date
2018-12-07
Lead Sponsor
X4 Pharmaceuticals
Target Recruit Count
15
Registration Number
NCT02680782
Locations
🇺🇸

Covance CRU, Inc., Daytona Beach, Florida, United States

Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma

Phase 1
Completed
Conditions
Clear Cell Renal Cell Carcinoma
Interventions
First Posted Date
2016-01-29
Last Posted Date
2024-10-03
Lead Sponsor
X4 Pharmaceuticals
Target Recruit Count
74
Registration Number
NCT02667886
© Copyright 2025. All Rights Reserved by MedPath